ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH AIDS William Paul To Step down; Aldige to Lead NCCR; Rimer Joins NCI

October 10, 1997

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

Oklahoma Cancer Center Recruits Four Professors.

June 15, 2001

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

ADT Does Not Raise Risk of Heart Attacks In Men With No History Of Heart Disease

November 25, 2011